Genmab — Februar 2019
-
Copenhagen, Denmark, February 12, 2019
DARZALEX split dosing regimen approved by U.S. FDA
Provides healthcare professionals with option to split first DARZALEX infusion over two consecutive days
Approval supported by data from EQUULEUS (MMY1001) clinical trial -
God morgen.

-
-
-
-
Godt for patienterne, men der kommer desværre nok ikke flere igennem systemet før der kommer flere stole. Det vil rykke med sc versionen. Synes også der mangler lidt nyt omkring RTOR i 1 line som gerne snart skulle blive godkendt. Helst inden regnskab.

-
Guidance er altid til aktuel kurs
-
Nu er det ikke alle, der er lige så useriøse omkring guidance som Genmab
-
Gen kravlede lige akkurat over bunden af guidanceintervallet med 4 omsætningsdage. Var vi kommet under usd 2b var milestone. Gen oplyste ikke om den risiko, men fastholdt guidance pba den højere dkk/usd
-
...milestone ikke blevet udløst...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind